All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

6 results

Do innovative medicines against cancer always have a real added value?

KCE Reports 343C (2021) During the past twenty years, a number of cancer treatments considered innovative have been introduced, such as monoclonal antibodies and immunotherapies. But what exactly should we expect from a new cancer treatment? That it prolongs life and/or that it improves quality of life.

Next generation sequencing gene panels for targeted therapy in oncology and haemato-oncology

KCE Reports 240C (2015)

Supportive treatment for cancer – Part 3: Treatment of pain: most common practices

KCE Reports 211C (2013)

Supportive treatment for cancer - Part 2: Prevention and treatment of adverse events related to chemotherapy and radiotherapy

KCE Reports 191C (2012) Please take note of the publication date of this guideline. From a methodological point of view, a guideline is generally considered obsolete after 5 years. It is therefore possible that some parts of this document are no longer relevant.

Supportive treatment for cancer - Part 1: exercice treatment

KCE Reports 185C (2012)

The volume of surgical interventions and its impact on the outcome: feasibility study based on Belgian data

KCE Reports 113C (2009)

You are here